Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice

Ähnliche Einträge

• A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice
  von: Kangyin Li, et al.
  Veröffentlicht: (2024)
• Erratum to “Evaluation of the Effectiveness and Safety of Sequential Vaccination With Inactivated SARS‐CoV‐2 Vaccine and Ad5‐nCoV Booster in Pediatric Liver Transplant Recipients”
  Veröffentlicht: (2024)
• Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections
  von: Jianhua Li, et al.
  Veröffentlicht: (2025)
• Maternal Vaccination and Protective Immunity Against SARS‐CoV‐2 Infection in Pups
  von: Kunpeng Liu, et al.
  Veröffentlicht: (2025)
• Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
  von: Jing Wang, et al.
  Veröffentlicht: (2024)